BACKGROUND & AIMS: Some patients develop multiple squamous cell carcinomas (SCCs) in the upper aerodigestive tract, attributed to field cancerization; alcohol consumption has been associated with this process. We examined the association between multiple areas of dysplastic squamous epithelium with the development of SCC of the esophagus or head and neck cancer, as well as alcohol consumption and smoking. METHODS: We examined 331 patients with early stage esophageal SCC using Lugol chromoendoscopy to evaluate the dysplastic squamous epithelium in the esophagus. Patients then were assigned to 3 groups, based on the number of Lugolvoiding lesions: A, no lesion; B, 1-9 lesions; or C, 10 or more lesions. Participants completed lifestyle surveys on their history of drinking, smoking, and diet. All participants were evaluated by laryngopharyngoscopy before registration; only those without head and neck cancer were included, except for patients with superficial SCC limited to the subepithelial layer. Lesions detected in the esophagus and head and neck by surveillance were considered to be metachronous. The study end point was the cumulative incidence of metachronous SCCs in the esophagus and head and neck after endoscopic resection of esophageal SCC, according to the grade of Lugol-voiding lesions. At study entry, all patients were instructed to abstain from alcohol and smoking. RESULTS: Over the 2-year study period, metachronous SCCs of the esophagus were detected in 4% of patients in group A, in 9.4% of patients in group B, and in 24.7% of patients in group C (P < .0001 for patients in group A vs B or B vs C). Head and neck SCCs were detected in none of Q6 Q7 Q8 S ynchronous and metachronous development of squamous cell carcinoma (SCC) in the upper aerodigestive tract including the esophagus and the head and neck region has been referred to as the phenomenon of "field cancerization" 1 and adversely affects patient survival. 2 Recent endoscopic imaging technology such as narrow-band imaging can detect early SCC, and minimally invasive endoscopic treatment can achieve cure and organ preservation. [3] [4] [5] [6] Conversely, cancer survivors after curative treatment are at risk for the development of metachronous multiple SCCs in the preserved organ. However, little is known about the interval from the first SCC to the metachronous SCC and the risk of metachronous SCC.
Squamous dysplasia has been believed to be a preneoplastic lesion of SCC, and it is identified easily as Lugolvoiding lesions (LVL) on Lugol chromoendoscopy. 7, 8 Some patients with esophageal SCCs have multiple LVLs in the background esophageal mucosa. [9] [10] [11] [12] [13] However, prospective data on the association between the grade of LVL and the risk of metachronous SCC are lacking. In addition, mutation of the TP53 gene in the background esophageal mucosa was shown as an early event of esophageal carcinogenesis. Moreover, TP53 gene mutations were detected even in the microscopically normal epithelium. 14 However, data on the association between the grade of LVL and TP53 status also are lacking. Follow-up data on LVL might provide important information about the risk of metachronous SCC.
Although field cancerization is associated closely with alcohol consumption and insufficient alcohol metabolism, 15, 16 the benefit of alcohol abstinence on the field cancerization phenomenon remains unclear. In this study, we evaluated the cumulative incidence of metachronous multiple SCCs in the esophagus and the head and neck region according to the grade of LVL, as well as the risk factors of metachronous multiple SCCs and the effect of alcohol and smoking abstinence on field cancerization.
Methods

Study Design
From September 2005 through May 2010, we prospectively recruited patients from 16 hospitals throughout Japan. This cohort study was approved by the institutional review board at each hospital, and we obtained written informed consent from all patients (UMIN
Q9
Clinical Trials Registry ID: UMIN000001676). The genetic analysis also was approved by the Institutional Review Board of Kyoto University Hospital, and all participants provided written informed consent (UMIN Clinical Trials Registry ID: UMIN000005466).
Study Population
Inclusion criteria of this cohort study were as follows: (1) newly diagnosed early SCC of the esophagus; (2) complete endoscopic resection by endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD); (3) tumor-negative vertical margins of resected specimens; (4) tumor invasion limited to the mucosa on histopathologic examination of resected specimens; (5) no additional treatment (surgical resection, radiotherapy, chemotherapy, and so forth) immediately after EMR or ESD; (6) no active head and neck cancer; (7) patients were evaluated by their attending physicians to be in good general condition, allowing at least 2 years of follow-up evaluation; and (8) written informed consent obtained from the patient. Exclusion criteria were as follows: (1) a history of chemotherapy for any other cancer or a history of surgical treatment or radiotherapy for head and neck cancer; (2) a history of iodine allergy; and (3) patients whom the investigator considered unsuitable as subjects.
We also prospectively examined TP53 mutations in the background esophageal mucosa in other patients with early esophageal SCC who were treated at Kyoto University Hospital.
Grading of LVL
LVL was graded according to the number of LVLs per endoscopic view (A, no lesions; B, 1-9 lesions; C, 10 lesions) ( Figure 1 ). Endoscopic images obtained from eligible patients at study entry were reviewed centrally in a blinded fashion by 3 endoscopists to determine the grade of LVL.
Survey of Lifestyle and Flushing Reaction After Drinking
At study entry, lifestyle surveys were conducted using a self-administered questionnaire ( Supplementary Figure 1) . The histories of drinking, smoking, and consumption of hightemperature foods, green-yellow vegetables, and fruit were documented carefully. The same questionnaire was used to obtain detailed information on each subject. Patient reports of facial flushing after drinking alcohol were presumed to be markers of insufficient alcohol metabolism owing to inactive aldehyde dehydrogenase-2 (ALDH2) genotype (present Q10 and past flushing and never flushing were indicative of active ALDH2). 17 
Definition of Synchronous and Metachronous Cancer
All candidates were surveyed by laryngoscopy by an otolaryngologist to confirm whether they had synchronous multiple cancers in the head and neck region before registration. The surveillance interval was within 6 months. Only patients without active head and neck cancer were eligible, except for patients with superficial SCCs limited to within the subepithelial layer. Lesions detected by surveillance before registration and lesions including the esophagus were defined as synchronous lesions. After registration, all of the patients were followed up by a planned schedule according to the protocol. If a new lesion was detected at the first follow-up evaluation (3 months after registration) or thereafter, such a lesion was defined as a metachronous lesion.
Follow-Up Examinations
Endoscopic examinations of the head and neck, esophagus, and stomach, as well as Lugol chromoendoscopy, were performed at 3-month intervals for up to 6 months after EMR or ESD. Subsequently, these examinations were repeated every 6 months. The head and neck region was examined by laryngoscopy by an otolaryngologist at the time of EMR or ESD and at 1-year intervals thereafter. 18 
Alcohol and Smoking Abstinence
At study entry, the physicians in charge handed a document describing the importance of alcohol and smoking abstinence to all patients and verbally instructed them to stop drinking and smoking. At each examination, we surveyed smoking status (nonsmoker or smoker; for smokers, the number of cigarettes smoked per day) and drinking status (nondrinker or drinker; for drinkers, the drinking frequency and amount of alcohol consumed) by self-reporting and instructed patients not to drink or smoke.
Histologic Analysis
Although the diagnosis of invasive SCC did not usually differ among the pathologists, the diagnosis of high-grade intraepithelial neoplasia sometimes was discordant. To control these differences, lesions with a diagnosis of high-grade intraepithelial neoplasia were reviewed centrally in a blinded fashion by 3 pathologists. Lesions present at enrollment as well as new lesions were examined. Lesions not diagnosed to be high-grade intraepithelial neoplasia or SCCs on central review were excluded from this analysis.
TP53 Mutation in Background Esophageal Mucosa
Biopsy specimens were taken from noncancerous background esophageal mucosa. Genomic DNA was extracted using the Gentra Puregene Tissue Kit protocol (Qiagen, Inc, Hilden, Germany) with several modifications, and a low frequency of TP53 mutations was detected by deep sequencing of the amplicons by using the TruSeq Amplicon Cancer Panel (Illumina, Inc, San Diego, CA) to sequence mutational hotspots. This cancer panel includes hotspots of TP53 mutation, but not all TP53 exons. The amplicon libraries were subjected to massively parallel sequencing using MiSeq (Illumina, Inc) with 170-bp paired-end reads. The sequencing data were imported to the CLC Genomics Workbench software Q11 (version 6.0.1), and low-quality data were trimmed by a quality limit of 0.001. The cleaned-up reads were mapped to the human genome (GRCh37_dbSNP135), and the somatic mutations were detected by the Quality-based Variant Detection command.
Statistical Analysis
We examined whether the grade of LVL was associated with the development of metachronous multiple SCCs in the esophagus and head and neck region. The number of patients required to detect a difference between grades A and B with a statistical power of 80% and a significance level of 5% was estimated assuming that the cumulative rate of metachronous SCCs in grades A, B, and C, would be 1%, 10%, and 30%, respectively, with a patient ratio of 4:4:2 and a drop-out rate of 10%. The total number of patients required was estimated to be 292. Under these conditions, the statistical power to detect a difference between grades A and C would be 99% or greater (significance level, 5%). The planned number of enrolled patients was set at 330, taking into account drop-outs and ineligible patients.
The Kaplan-Meier method and the log-rank test were performed for the analysis of development of a second primary SCC in the esophagus and the head and neck region. We defined the time to development from the day of endoscopic treatment to the day of endoscopic diagnosis of a second primary SCC. The person-year method was used to calculate the total number of multiple cancers arising in the esophagus and head and neck per 100 person-years (ie, a patient could have multiple events); the Poisson regression analysis was used to estimate the sex-and age-adjusted Q12 relative risk (RR) of all arising events. A Cox proportional-hazards model was used to estimate the sex-and age-adjusted hazard ratio (RR) and 95% confidence interval (CI) of the primary event. The analysis of end points was conducted after the completion of at least 2 years of follow-up observation for all patients from the time of enrollment. Data on patients in whom follow-up examinations were not completed were censored at the last observation. All data were analyzed with SAS Q13 (version 9). All authors had access to the study data and reviewed and approved the final manuscript. 241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300   301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360 CLINICAL AT
Results
Study Population
A total of 332 patients with early esophageal SCC were enrolled. One patient refused to participate in this cohort study. The other 331 patients were registered and underwent the preplanned follow-up examinations. One patient was excluded because the lesion was not diagnosed definitively as high-grade intraepithelial neoplasia or invasive SCC on central review of the pathologic assessment ( Figure 2) . Table 1 summarizes the baseline characteristics of the 330 patients according to the grade of LVL. The median followup period was 49.4 months (range, 1.3-81.2 mo). The proportion of men was higher in the more severe LVL grades (62.0%, 85.1%, and 93.4%, respectively; P < .0001 for A or B vs C). The largest subgroup according to age was 60 to 69 years in grade C and 70 years or older in grades A and B. After adjusting for sex and age, the LVL grade was associated with progressively higher proportions of heavy drinkers (27.7%, 26.2%, and 52.8%, respectively; P < .0001 for trend, vs others), heavy smokers (41.1%, 65.9%, and 71.0%, respectively; P < .0001 for trend), not eating greenyellow vegetables almost every day (52.0%, 54.9%, and 71.3%, respectively; P ¼ .021 for trend), and patients with a low body mass index (23.4%, 32.0%, and 37.4%, respectively; P ¼ .027 for trend).
Primary and Secondary Outcomes
LVL grade was associated with progressive increases in the 2-year cumulative incidence of metachronous multiple SCCs (esophagus: 4.0%, 9.4%, and 24.7%, respectively; P < .0001 for A or B vs C; head and neck region: 0.0%, 1.7%, and 8.6%, respectively; P ¼ .016 for A vs C and P ¼ .008 for B vs C; both: 4.0%, 10.0%, and 31.4%, respectively; P < .0001 for A or B vs C) ( Figure 3 ).
LVL grade was associated with progressive increases in the total number of metachronous multiple SCCs per 100 person-years (esophagus: RR, 1.91 and 7.41 for grades B and C, respectively, vs grade A; P < .0001 for trend; head and neck region: RR, 0.00 and 5.74 for grades A and C, respectively, vs grade B; P < .0001 for trend; both: RR, 2.19 and 9.05 for grades B and C, respectively, vs grade A; P < .0001 for trend) ( Table 2 ). The frequency of events was notably high in grade C (18.9, 5.8, and 24.7 per 100 person-years in esophagus, head and neck region, and both, respectively).
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TP53 Gene Alteration in Background Esophageal Mucosa
To examine whether mutations of genes such as TP53 occurred in the noncancerous esophageal mucosa with multiple LVLs and whether the mutation frequency was associated with the severity of LVLs, we performed deep sequencing of the TP53 gene amplicon using biopsy specimens of noncancerous esophageal mucosa in patients with or without multiple LVLs. These samples were obtained from 38 early esophageal SCC Q14 cases independent from our present cohort study. The clinical characteristics are summarized in Supplementary Tables 1 and 2   Q15 , and the detected low frequency of TP53 mutations (2% of total reads) are listed in Supplementary Table 3 . Our study showed that the number of cases that had a TP53 mutation was 3 of 7 (42.9%) in grade A, 5 of 9 (55.6%) in grade B, and 17 of 22 (77.3%) in grade C ( Supplementary Figure 2) . Of note, several mutations (2-6 mutations) of the TP53 gene were found simultaneously in biopsy specimens of noncancerous esophageal mucosa in patients with grade C LVL ( Supplementary Figure 2) . The median mutation frequency of TP53 genes in biopsy specimens was 0%, 2.0%, and 10.1% in grades A, B, and C, respectively. The median in grade C was significantly higher than that in grade A (P ¼ .04) ( Supplementary Figure 3 ).
Effect of Alcohol and Smoking Abstinence on the Development of Metachronous SCC
As shown in Supplementary Figure 4 , 69 (30.9%) of 223 patients who drank 1 U/day (22 g of ethanol) or more at baseline abstained from drinking alcohol, and 69 (53.5%) of 129 patients who had smoked at baseline abstained from smoking. The cumulative incidence of metachronous multiple SCCs in the esophagus was shown according to the status of drinking alcohol and smoking (Figure 4 ). Hazard ratios were adjusted for sex, age, LVL grade, alcohol intake at baseline, and alcohol flushing.
Alcohol abstinence decreased the risk of developing metachronous multiple SCCs of the esophagus (adjusted hazard ratio, 0.47; 95% CI, 0.25-0.91; P ¼ .025) ( Figure 4A ). The risk reduction was especially large in grade C LVL (adjusted hazard ratio, 0.23; 95% CI, 0.09-0.60; P ¼ .003) ( Figure 4B ). In contrast, smoking abstinence did not decrease the risk of developing metachronous multiple SCCs of the esophagus (all: adjusted hazard ratio, 0.59; 95% CI, 0.29-1.18; P ¼ .13; grade C LVL: adjusted hazard ratio, 0.73; 95% CI, 0.32-1.67; P ¼ .45) ( Figure 4C and D, respectively).
Discussion
We found that patients with grade C LVL were at significant risk for the development of metachronous multiple SCCs in the esophagus and the head and neck region. Furthermore, TP53 mutation in the background esophageal mucosa was associated with an increased grade of LVL. These results clearly supported the theory of field cancerization in which genetic alteration in the background squamous epithelium might accumulate and increase the potential to develop metachronous multiple SCCs. In addition, alcohol abstinence significantly decreased the development of metachronous SCCs, especially in the patients with grade C LVL. This result indicates that alcohol abstinence should be encouraged to reduce the risk of metachronous multiple SCCs after curative treatment.
Although the field cancerization phenomenon in the upper aerodigestive tract has been well known for more than half a century, it has been difficult to detect early cancer in this region. A randomized controlled trial found that narrow-band imaging effectively can detect early SCC in the esophagus and the head and neck region. 3 In patients with early SCC, organs can be preserved by endoscopic curative treatment, but the preserved organs are affected strongly by the field cancerization phenomenon. Therefore, an effective surveillance strategy after treatment and methods to prevent metachronous multiple SCCs are needed in survivors of esophageal SCC. 601  602  603  604  605  606  607  608  609  610  611  612  613  614  615  616  617  618  619  620  621  622  623  624  625  626  627  628  629  630  631  632  633  634  635  636  637  638  639  640  641  642  643  644  645  646  647  648  649  650  651  652  653  654  655  656  657  658  659  660   661  662  663  664  665  666  667  668  669  670  671  672  673  674  675  676  677  678  679  680  681  682  683  684  685  686  687  688  689  690  691  692  693  694  695  696  697  698  699  700  701  702  703  704  705  706  707  708  709  710  711  712  713  714  715  716  717  718  719  720 Data on the interval from the first SCC to the development of a second primary metachronous SCC have been limited, largely because of dismal survival, complete esophageal resection on diagnosis, poor follow-up evaluation, and lack of effective surveillance programs. In this study, we focused on patients with early esophageal SCC who could achieve cure and organ preservation. The frequency of events was notably low in grade A. The 2-year cumulative incidence of metachronous multiple SCCs and the total number of metachronous multiple SCCs per 100 person-years were 4.0%/2.8, 0.0%/0.0, and 4.0%/2.8 in the esophagus, head and neck region, and both, respectively. On the other hand, the frequency of events was notably high in grade C. The 2-year cumulative incidence of metachronous multiple SCCs and the total number of metachronous multiple SCCs per 100 person-years were 24.7%/18.9, 8.6%/ 5.8, and 31.4%/24.7 in the esophagus, head and neck region, and both, respectively. These results indicated that effective surveillance programs according to the grade of LVL or effective adjuvant strategies according to the grade of LVL are required to detect metachronous SCC earlier.
There has been no effective biomarker for the risk of the field cancerization phenomenon. In this study, we clearly showed that an increase in the grade of LVL is associated closely with the risk of metachronous SCC. In addition, grade C LVL and a flushing reaction after drinking alcohol are 721  722  723  724  725  726  727  728  729  730  731  732  733  734  735  736  737  738  739  740  741  742  743  744  745  746  747  748  749  750  751  752  753  754  755  756  757  758  759  760  761  762  763  764  765  766  767  768  769  770  771  772  773  774  775  776  777  778  779  780   781  782  783  784  785  786  787  788  789  790  791  792  793  794  795  796  797  798  799  800  801  802  803  804  805  806  807  808  809  810  811  812  813  814  815  816  817  818  819  820  821  822  823  824  825  826  827  828  829  830  831  832  833  834  835  836  837  838  839  840 CLINICAL AT predictors of metachronous multiple SCCs. We previously reported that multiple LVLs in patients with SCC in the esophagus and the head and neck region was associated with ALDH2 inactive genotype and metachronous SCC in the esophagus and the head and neck region. 13, 19, 20 These data mean that cancer survivors with flushing reaction after drinking alcohol or multiple LVLs in the background mucosa, or both, should be considered as having a higher risk of field cancerization. A recent meta-analysis showed that the alcohol-related risk of esophageal SCC is reversible after alcohol abstinence, and 16 years are required until all increased risk disappears. 21 In our study, with a median follow-up period of only 49.4 months (range, 1.3-81.2 mo), the risk of metachronous SCC significantly decreased after alcohol abstinence, especially among the patients with grade C LVL, in whom the hazard ratio decreased to 0.23. These data are very important for reducing the risk of metachronous SCC in cancer survivors who have received curative treatment.
The median follow-up time in our study was 49.4 months, which might be too short to draw strong recommendations about the value of surveillance intervals.
However, even in this short period, the patients with grade C LVL had a risk of metachronous multiple SCCs in the esophagus and the head and neck region. This means that close surveillance may be required for the patients with esophageal cancer who were treated successfully. Clinically, the grade of LVL on iodine staining of the background mucosa should be evaluated initially. If the grade suggests a risk of cancer, narrow-band imaging should be performed as surveillance for the early detection of cancer.
We showed that the TP53 mutation was seen even in noncancerous lesions in patients with early esophageal SCC, and the frequency of the TP53 mutation was associated with the severity of LVL grade. We believe these data help explain the mechanisms of metachronous esophageal carcinogenesis. In this study, we obtained biopsy samples from Lugolstained lesions, in which glycogen granules are rich and structural atypia is not seen. Such mucosa was assumed to be "non Q16 -cancerous" esophageal epithelium. 22 However, we could not exclude the possibility that the greater the number of LVL lesions present in the patient, the more likely the possibility that biopsy specimens from normal mucosa still contain cryptic dysplasia that would not have been detected Variables were selected from all the variables listed above Q18 by the stepwise procedure with P < .15 for entry and removal, and the relative risks were shown for the selected variables. 841  842  843  844  845  846  847  848  849  850  851  852  853  854  855  856  857  858  859  860  861  862  863  864  865  866  867  868  869  870  871  872  873  874  875  876  877  878  879  880  881  882  883  884  885  886  887  888  889  890  891  892  893  894  895  896  897  898  899  900   901  902  903  904  905  906  907  908  909  910  911  912  913  914  915  916  917  918  919  920  921  922  923  924  925  926  927  928  929  930  931  932  933  934  935  936  937  938  939  940  941  942  943  944  945  946  947  948  949  950  951  952  953  954  955  956  957  958  959  960 by Lugol staining alone. In addition, we could not address the difference regarding TP53 mutations between the primary lesion and the noncancerous background esophageal mucosa because we did not obtain DNA samples from primary lesions. Moreover, we could not assess whether the different TP53 mutations identified in the same case were derived from monoclonal or polyclonal origin. These limitations should be clarified further in future studies.
In conclusion, the grade of LVL is a useful predictor of the risk of metachronous multiple SCCs arising in the esophagus and the head and neck region in survivors of esophageal cancer. Alcohol abstinence is required to reduce the risk of metachronous multiple SCCs in the esophagus.
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Note: To access the supplementary material accompanying this article, visit the online version of Gastroenterology at www.gastrojournal.org, and at http://dx.doi.org/10.1053/ j.gastro.2016.07.040. Supplementary Figure 1 . A self-administered questionnaire for lifestyle surveys.
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Supplementary Figure 2 . TP53 mutations in biopsy specimens of noncancerous background esophageal mucosa. Deep sequencing of the TP53 gene amplicon was performed to detect small frequencies of mutations (2% of total reads). A rectangle shows a biopsy specimen of each case. A red plot shows a mutation of TP53, and the plot size conforms to the mutation frequency. The 38 cases are divided according to their LVL grade (grade A, 7 cases; grade B, 9 cases; and grade C, 22 cases). ALDH2*1/*1 (ALDH2 wild-type homozygotes), ALDH2*1/*2 (ALDH2 heterozygotes), and ALDH2*2/*2 (ALDH2 mutant homozygotes) are shown with blue rectangles, red rectangles, and yellow rectangles, respectively. 1201  1202  1203  1204  1205  1206  1207  1208  1209  1210  1211  1212  1213  1214  1215  1216  1217  1218  1219  1220  1221  1222  1223  1224  1225  1226  1227  1228  1229  1230  1231  1232  1233  1234  1235  1236  1237  1238  1239  1240  1241  1242  1243  1244  1245  1246  1247  1248  1249  1250  1251  1252  1253  1254  1255  1256  1257  1258  1259  1260 Supplementary 
